Intravenous pamidronate therapy in osteogenesis imperfecta: response to treatment and factors influencing outcome: a novel molecular mechanism.
Namazi
Hamid
H
D050071:Bone Density Conservation Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002118:Calcium / Q000097:blood; D004164:Diphosphonates / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D010013:Osteogenesis Imperfecta / Q000188:drug therapy* / Q000503:physiopathology; D000077268:Pamidronate; D053245:RANK Ligand / Q000378:metabolism; D014807:Vitamin D / Q000097:blood
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D053245:RANK Ligand; D014807:Vitamin D; D000077268:Pamidronate; D002118:Calcium